Development of Gene therapy for HLH due to perforin deficiency and for XLP1

被引:0
|
作者
Gaspar, Bobby [1 ]
Carmo, Marlene [1 ]
Arumugam, Paritha [2 ]
Alonso-Ferrero, Maria [1 ]
Schambach, Axel [3 ]
Baum, Christopher [3 ]
Risma, Kimberly [2 ]
Malik, Punam [2 ]
Jordan, Michael [2 ]
Rivat, Christine [1 ]
Booth, Claire [1 ]
Thrasher, Adrian [1 ]
机构
[1] UCL, London, England
[2] CCHMC, Cincinnati, OH USA
[3] MHH, Hannover, Germany
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:A9 / A9
页数:1
相关论文
共 50 条
  • [1] Development of Gene Therapy for HLH Due to Perforin Deficiency
    Carmo, M.
    Booth, C.
    Montiel-Equihua, C. A.
    Schambach, A.
    Baum, C.
    Thrasher, A. J.
    Gaspar, H. B.
    HUMAN GENE THERAPY, 2010, 21 (04) : 508 - 509
  • [2] Development of gene therapy for haemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency
    Carmo, M.
    Montiel-Equihua, C. A.
    Schambach, A.
    Baum, C.
    Thrasher, A. J.
    Gaspar, H. B.
    HUMAN GENE THERAPY, 2011, 22 (10) : A46 - A47
  • [3] Development of gene therapy for hemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency
    Carmo, Marlene
    Arumugam, Paritha
    Montiel-Equihua, Claudia A.
    Alonso-Ferrero, Maria E.
    Schambach, Axel
    Baum, Christopher
    Risma, Kimberly
    Malik, Punam
    Thrasher, Adrian J.
    Jordan, Michael B.
    Gaspar, Bobby
    HUMAN GENE THERAPY, 2012, 23 (05) : A3 - A3
  • [4] Development of gene therapy for haemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency
    Carmo, M.
    Booth, C.
    Montiel-Equihua, C. A.
    Schambach, A.
    Baum, C.
    Thrasher, A. J.
    Gaspar, H. B.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1455 - 1455
  • [5] Development of Gene Therapy for Hemophagocytic Lymphohistiocytosis (HLH) Due to Perforin Deficiency
    Carmo, Marlene
    Arumugam, Paritha
    Montiel-Equihua, Claudia A.
    Alonso-Ferrero, Maria E.
    Tiwari, S.
    Schambach, Axel
    Baum, Christopher
    Risma, Kimberly
    Malik, Punam
    Thrasher, Adrian J.
    Jordan, Michael B.
    Gaspar, Bobby
    MOLECULAR THERAPY, 2012, 20 : S125 - S126
  • [6] DEVELOPMENT OF GENE THERAPY FOR HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) DUE TO PERFORIN DEFICIENCY
    Carmo, M.
    Arumugam, P.
    Montiel-Equiha, C.
    Alonso-Ferrero, M.
    Schambach, A.
    Baum, C.
    Risma, K.
    Malik, P.
    Thrasher, A.
    Jordan, M.
    Gaspar, B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 131 - 131
  • [7] Development of gene therapy for hemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency - corrected T cell transplant as control therapy
    Carmo, Marlene
    Calero-Garcia, Miguel
    Thrasher, Adrian J.
    Gaspar, H. Bobby
    HUMAN GENE THERAPY, 2014, 25 (05) : A9 - A9
  • [8] Development of gene therapy for hemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency - investigation of whether expression of perforin in stem cells has a toxic effect
    Carmo, Marlene
    Arumugam, Paritha
    Montiel-Equihua, Claudia A.
    Alonso-Ferrero, Maria E.
    Schambach, Axel
    Baum, Christopher
    Risma, Kimberly
    Malik, Punam
    Thrasher, Adrian J.
    Jordan, Michael B.
    Gaspar, Bobby
    HUMAN GENE THERAPY, 2013, 24 (05) : A15 - A15
  • [9] Development of Gene Therapy for Hemophagocytic Lymphohistiocytosis (HLH) Due To Perforin Defi ciency - Corrected T Cell Transplant as Control Therapy
    Carmo, Marlene
    Calero-Garcia, Miguel
    Thrasher, Adrian J.
    Gaspar, H. Bobby
    MOLECULAR THERAPY, 2014, 22 : S8 - S9
  • [10] Lentiviral vector mediated gene therapy for X-linked lymphoproliferative disease (XLP1) restores humoral and cellular functions
    Rivat, Christine
    Booth, Claire
    Blundell, Michael
    Thrasher, Adrian J.
    Gaspar, Hubert B.
    HUMAN GENE THERAPY, 2012, 23 (05) : A8 - A8